Home › NDC Lookup › Drug shortages › Propranolol Hydrochloride Injection

Propranolol Hydrochloride Injection shortage

Propranolol Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 2 affected products. The reported reason: Shortage of an active ingredient. This page was last refreshed from FDA data on Oct 3, 2026.

Current ⚠ Supply risk: High Cardiovascular 2 products 2 manufacturers 1,068 days · 2.9 yr First posted Oct 31, 2023 Updated Sep 18, 2026
Here’s the bottom line

Propranolol injection is in shortage due to a shortage of its active ingredient. The 1 mg/1 mL strength still has some supply — Fresenius Kabi suggests checking wholesalers for available inventory, though Hikma has no recovery date set.

Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
2
Affected NDCs
2
Reporting manufacturers
1/2
Reporting mfrs supplying
1/1
Affected strengths supplied
50%
NDCs unavailable
1,068
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 3, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Propranolol Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
2 NDCs
Available 1 Unavailable 1
Affected strengths still supplied
Among manufacturers reporting this shortage
1/1 strengths
Sourceable 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
1/2 makers
With supply 1 No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Propranolol Hydrochloride Injection from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Plus 15 alternative dosage forms of Propranolol Hydrochloride.
See all other options & details →
Shortage timeline
  1. Sep 18, 2026
    Currently in shortage
    2 of 2 products affected.
  2. Sep 15, 2026
    FDA refreshed this shortage record
    1 product updated.
  3. Oct 31, 2023
    First reported to the FDA
    2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
Current Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) NDC 63323-0604-01 — Available Check wholesalers for inventory —
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 800-631-2174 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
Current Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) NDC 00143-9872-10 — Unavailable Estimated recovery: TBD Shortage of an active ingredient

These rows are manufacturer reports to the FDA for Propranolol Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Propranolol Hydrochloride Injection? options further down this page.

Why is Propranolol Hydrochloride Injection in shortage?

The shortage of propranolol hydrochloride injection (1 mg/1 mL) from Hikma Pharmaceuticals USA comes down to one key issue — they don't have enough of the active ingredient, propranolol, to keep making it right now. As for when Hikma expects to have it back in stock, that's listed as "TBD," meaning they haven't been able to give a recovery date yet.

It's worth knowing that this report covers only Hikma's version of this specific product. Fresenius Kabi USA is also listed in this FDA report, and their 1 mg/1 mL propranolol injection is shown as currently available — so checking with wholesalers for that supply may be an option worth exploring.

FDA reason code(s): Shortage of an active ingredient

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Propranolol Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Propranolol Hydrochloride Injection?

Propranolol Hydrochloride Injection is currently on the FDA drug-shortage list, and I want to walk you through what that means for your supply.

There is only one strength of this injection, 1 mg/1 mL, and it still has an available source. Two manufacturers are listed on this shortage record. One (Hikma) reports its 1 mg/1 mL as unavailable, while the other (Fresenius Kabi) reports the same strength as available and suggests checking wholesalers for inventory. So the strength you take does have a supplier right now, even though half of the listed products are marked unavailable.

The FDA-reported reason is a shortage of an active ingredient, and this situation has lasted over a year. An estimated recovery date has not been set. Supply may vary from one pharmacy to the next, since this national data may not match local stock.

Here is what I suggest:

  • Do not stop, skip, or change your dose on your own.
  • Ask your pharmacy to order the 1 mg/1 mL from a manufacturer that still has it — pharmacies can check wholesalers and other suppliers.
  • If your pharmacy cannot locate it, ask your prescriber or pharmacist about the best options for you.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls.

See “Where else can I get Propranolol Hydrochloride Injection?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Propranolol guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Propranolol guide →

Where else can I get Propranolol Hydrochloride Injection?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Propranolol Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Alternative dosage forms of Propranolol Hydrochloride

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 8 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Propranolol Hydrochloride 1 mg/mLNDC 00143-9872-10 Hikma 10 vials — AP FDA listed
Propranolol 1 mg/mLNDC 00404-9999-01 Henry 1 vial — AP FDA listed
Propranolol Hydrochloride 1 mg/mLNDC 51662-1338-01 HF 1 ml — AP FDA listed
Propranolol 1 mg/mLNDC 51662-1700-01 HF 1 ml — AP FDA listed
Propranolol 1 mg/mLNDC 63323-0604-01 Fresenius 10 vials — AP FDA listed
Propranolol Hydrochloride 1 mg/mLNDC 71872-7096-01 Medical 1 vial — AP FDA listed
Propranolol 1 mg/mLNDC 71872-7195-01 Medical 1 vial — AP FDA listed
Propranolol 1 mg/mLNDC 84549-0604-01 ProPharma 1 ml — AP FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Propranolol Hydrochloride Injection — that fall in the same broad treatment class (beta-adrenergic blocking agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 043103
GCN 92875
HICL code 002101
Ingredient (HICL) Propranolol Hcl
HIC1 code J
Therapeutic class — broad (HIC1) Autonomic Nervous System
HIC2 code J7
Therapeutic class — intermediate (HIC2) Antiadrenergics
HIC3 code J7C
Therapeutic class — specific (HIC3) Beta-Adrenergic Blocking Agents
AHFS code 12:16.08.04
AHFS class Non-Sel. Beta-Adrenergic Blocking Agents
FDB label name PROPRANOLOL 1 MG/ML VIAL
FDB brand name Propranolol Hcl
Legend status F — Federal legend — prescription drug or device
GPI-1433100040102005
GPI classPropranolol HCl
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Propranolol Hydrochloride Injection shortage FAQs

Is Propranolol Hydrochloride Injection in shortage?
Yes — the FDA currently lists Propranolol Hydrochloride Injection in shortage (status: “Current”, first reported Oct 31, 2023). 2 of 2 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Propranolol Hydrochloride Injection in shortage?
The manufacturer-reported reason on file with the FDA: Shortage of an active ingredient.
Which products are affected?
Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) (NDC 63323-0604-01); Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) (NDC 00143-9872-10). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Propranolol Hydrochloride Injection be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Propranolol Hydrochloride somewhere?
15 alternative dosage forms of Propranolol Hydrochloride are also listed. See “Where else can I get Propranolol Hydrochloride Injection?” above — stock still varies by pharmacy.
What should I do if I take Propranolol Hydrochloride Injection?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Propranolol Hydrochloride Injection shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages